Skip to content

Microscopy Imaging of Whole-mount Stained Human Tissues

Microscopy Imaging of Whole-mount Stained Human Tissues: Development of an Imaging Platform for Intraoperative Tumor Margin Delineation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05689112
Enrollment
250
Registered
2023-01-18
Start date
2023-01-10
Completion date
2025-12-31
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor, Brain, Tumor, Breast, Tumor Skin

Keywords

intraoperative assessment, whole-mount H&E staining, surgical border assessment

Brief summary

The goal of this clinical trial is to develop an imaging platform for intraoperative tumor margin delineation in 250 cases of tumor-suffered patients. The main questions it aims to answer are: • to develop the protocol of rapid assessment of surgical specimens without need for fixation, embedding, and cryosectioning required for conventional histopathology. Participants will provide a small piece of their surgical specimens from tumor removal surgery . If there is a comparison group: Researchers will compare normal specimens to see if we can observe the difference.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients who are more than 20 years old. 2. Diagnosed as patients suffered by skin tumor, brain tumor and breast tumor.

Exclusion criteria

1. Patients who can't speak and communicate with others. 2. Patients who can't make eventual and exact pathological assessment for his/her diseases. 3. Patients who only can fit for slicing tumor. 4. Removed tissues which obviously vary after severe ray radiation under microscopy observation. 5. Diameter of tumors are under 1 centimeter. 6. Breast carcinoma in situ.

Design outcomes

Primary

MeasureTime frameDescription
The assessment between tumor cases and control cases5 yearsDo comparison with images acquired by our microscopy (with the whole-mount staining method) and bright field microscopy (with standard FFPE method) and do assessment to interpret tumor characteristics

Countries

Taiwan

Contacts

Primary ContactYi-Hua YH Liao, PhD
yihualiao@ntu.edu.tw+886-23123456
Backup ContactYao-Chen YC Tseng, Master
opiuy1234567@yahoo.com.tw+886-33661552

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026